Liver Disease News and Research

RSS

The liver is one of the largest solid organs of the body. It is located in the upper right part of the abdomen. Most of the organ lies under cover of the rib cage.

Study calls for new gold standard in research to treat non-alcoholic steatohepatitis

A new study by scientists from the Vrije Universiteit Brussel calls for a new gold standard in research to treat non-alcoholic steatohepatitis, an obesity-linked chronic liver disease impacting millions of people of all ages worldwide, which can progress to liver cancer if untreated, creating a massive strain on an already overburdened healthcare system.

18 Jul 2018

Fish consumption associated with lower risk of early death

Consumption of fish and long-chain omega-3 fatty acids was associated with lower risks of early death in a Journal of Internal Medicine study.

18 Jul 2018

Non-surgical management found to be feasible option for penetrating kidney trauma

Trauma is the sixth leading cause of death worldwide, and recent studies suggest that 16 percent of renal trauma occurs from a penetrating injury, such as a gunshot wound, stabbing or piercing injury from a car accident.

16 Jul 2018

Researchers find experimental compound to treat fibrotic diseases

Normal scar tissue forms to heal an internal wound and quietly retreats when the job is done. But in many common diseases - kidney, liver and lung fibrosis -- the scar tissue goes rogue and strangles vital organs. These diseases are largely untreatable and ultimately fatal.

13 Jul 2018

Study uncovers possible link between iron loading, alcohol intake and mortality

Drinking heavily results in uncontrolled iron absorption into the body, putting strain on vital organs and increasing the risk of death, according to a new study published in the journal Clinical Nutrition.

12 Jul 2018

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.

9 Jul 2018

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

State prisons across the U.S. are failing to treat at least 144,000 inmates who have hepatitis C, a curable but potentially fatal liver disease, according to a recent survey and subsequent interviews of state corrections departments.

9 Jul 2018

Nonalcoholic fatty liver disease costs the U.S. healthcare system $32 billion annually

Nonalcoholic fatty liver disease, or NAFLD, which affects roughly 100 million Americans, costs the United States healthcare system $32 billion annually, according to a first-of-its-kind study by Intermountain Healthcare researchers on the economic impact of the disease.

3 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Researchers develop inexpensive blood test to diagnose hepatitis B patients

A simple $20 blood test could help diagnose thousands of patients with hepatitis B in need of treatment in some of Africa's poorest regions.

2 Jul 2018

People with co-existing HCV and AUD experience greater psychiatric, immune problems

Infection with the hepatitis C virus is a contagious liver disease with symptoms that range from mild illness for a few weeks to serious, lifelong liver problems.

28 Jun 2018

Antidepressant drug appears to effectively stop progression of PBC

Gail Wright considered herself healthy. She had no idea she had a chronic liver disease. "I was at a routine check-up and my doctor said my liver enzymes were elevated. I was sent to a specialist but I wasn't too worried. I didn't have any symptoms."

27 Jun 2018

Individual species of lipids may be better signatures of metabolic health

Heart disease is the number one killer in the United States, and high triglyceride levels in the blood are cited as just one of several risk factors. Millions of lipid panels, blood tests that look at cholesterol levels as well as triglycerides, are performed in clinics each year.

27 Jun 2018

Chemical compounds produced by gut bacteria could help spot early stages of liver disease

Chemical compounds produced by the bacteria in our gut could be used to spot the early stages of liver disease, according to new research.

25 Jun 2018

Scientists discover secret to success of antiviral gene

It's been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying.

25 Jun 2018

Coffee and the heart – four strong cups a day is beneficial finds study

According to a new study four cups of strong coffee might be the amount that would keep the hearts of older adults healthy. The latest study titled, “CDKN1B/p27 is localized in mitochondria and improves respiration-dependent processes in the cardiovascular system—New mode of action for caffeine,” was published on 21st of June 2018 in the journal PLOS Biology.

25 Jun 2018

Review: Stem cells appear to help fight obesity in animal models

Obesity is an increasing global health problem associated with several comorbidities and a high risk of mortality.

21 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Ultrasound-based technology for assessing overweight adolescents with liver disease

Researchers from Charité - Universitätsmedizin Berlin have successfully tested a new technology for use in the assessment of overweight adolescents with liver disease.

18 Jun 2018

Extensive lipidomics studies reveal signatures of metabolic health and disease

Scientists from EPFL and the University of Wisconsin-Madison have carried out one of the most extensive lipidomics studies to date, connecting almost 150 different lipid species to their respective genetic regulators, revealing signatures of metabolic health and disease.

13 Jun 2018

Liver Disease News and Research

Further Reading

Study calls for new gold standard in research to treat non-alcoholic steatohepatitis

Fish consumption associated with lower risk of early death

Non-surgical management found to be feasible option for penetrating kidney trauma

Researchers find experimental compound to treat fibrotic diseases

Study uncovers possible link between iron loading, alcohol intake and mortality

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

Nonalcoholic fatty liver disease costs the U.S. healthcare system $32 billion annually

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Researchers develop inexpensive blood test to diagnose hepatitis B patients

People with co-existing HCV and AUD experience greater psychiatric, immune problems

Antidepressant drug appears to effectively stop progression of PBC

Individual species of lipids may be better signatures of metabolic health

Chemical compounds produced by gut bacteria could help spot early stages of liver disease

Scientists discover secret to success of antiviral gene

Coffee and the heart – four strong cups a day is beneficial finds study

Review: Stem cells appear to help fight obesity in animal models

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Ultrasound-based technology for assessing overweight adolescents with liver disease

Extensive lipidomics studies reveal signatures of metabolic health and disease

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News